Ebb & Flow

Publicly quoted European biotechs, beaten down by tough capital market conditions, will take some comfort from last week's news that the Netherlands' largest pension group is committed to increasing its focus on small-cap life science plays. With E217 billion ($338.4 billion) in assets under management, APG Investments, a Dutch pension services business, has turned to Life Sciences Partners Group to assist it in identifying investment opportunities.

"LSP will act as a gatekeeper for APG as if it was an LP in one or our funds. We will be responsible for providing ready-to-go investment opportunities in a pro-active manner that APG will subsequently invest in," Mark Wegter, LSP general partner, told Ebb & Flow. ...